| Literature DB >> 34884352 |
Mohammad Golriz1, Mohammadsadegh Sabagh1, Golnaz Emami1, Sara Mohammadi1, Ali Ramouz1, Elias Khajeh1, Omid Ghamarnejad1, Christian Morath2, Markus Mieth1, Yakup Kulu1, Martin Zeier2, Arianeb Mehrabi1.
Abstract
Lymphocele is a common complication following kidney transplantation (KTx). We aimed to evaluate the preventive effect of peritoneal fenestration during KTx in reducing lymphocele. From January 2001, the data of all KTx were prospectively gathered in our digital data bank. From 2008, preventive peritoneal fenestration was performed as a routine procedure for all patients with KTx. Between 2001 and 2008, 579 KTx were performed without preventive peritoneal fenestration. To compare the results between with and without peritoneal fenestration, the same number of patients after 2008 (579 patients) was included in this study. The pre-, intra-, and postoperative data of the patients in these two groups were analyzed and compared, especially regarding the postoperative different types of lymphocele formation. The mean recipient age was 52.6 ± 13.8, and 33.7% of the patients were female. Type C lymphocele was significantly lower in the group with preventive fenestration (5.3% vs. 8.8%, p = 0.014 for 31/579 vs. 51/579). Peritoneal dialysis and implantation of the kidney in the left fossa were independently associated with a higher rate of type C lymphocele (OR 2.842, 95% CI 1.354-5.967, p = 0.006 and OR 3.614, 95% CI 1.215-10.747, p = 0.021, respectively). The results of this study showed that intraoperative preventive peritoneal fenestration could significantly reduce type C lymphocele.Entities:
Keywords: consensus; lymphatic complications; preventive fenestration; surgical complication
Year: 2021 PMID: 34884352 PMCID: PMC8658067 DOI: 10.3390/jcm10235651
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Comparison of characteristics and post-transplant outcomes of the patients with lymphocele formation after KTx between preventive fenestration group and control group.
| Donor | Preventive Fenestration | No Preventive Fenestration | |
|---|---|---|---|
| Brain dead/Living donor | 55 (74.3%)/19 (25.7%) | 73 (88.0%)/10 (12.0%) |
|
| Gender |
| ||
| Female/Male | 44 (59.4%)/30 (40.6%) | 35 (42.2%)/48 (57.8%) | |
| Age (years) | 56.9 ± 12.0 | 53.1 ± 14.5 | 0.105 |
| BMI (Kg/m2) | 26.3 ± 5.0 | 25.4 ± 4.5 | 0.371 |
| Side of donor kidney (Left/ Right) | 34 (45.9%)/40 (54.1%) | 38 (48.1%)/41 (51.9%) | 0.867 |
|
| |||
| Gender (Female/Male) | 26 (35.1%)/48 (64.9%) | 27 (32.5%)/56 (67.5%) | 0.710 |
| Age (year) | 52.3 ± 14.6 | 52.8 ± 13.2 | 0.844 |
| BMI (kg/m2) | 25.5 ± 4.2 | 24.9 ± 3.9 | 0.384 |
| Indication of KTx | 0.985 | ||
| Glomerulonephritis | 32 (43.2%) | 34 (41.0%) | |
| Congenital disease | 19 (25.7%) | 24 (28.9%) | |
| Diabetes/hypertension | 8 (10.8%) | 11 (13.3%) | |
| Obstructive nephropathy | 2 (2.7%) | 3 (3.6%) | |
| Vascular disease | 2 (2.7%) | 2 (2.4%) | |
| Tubulointerstitial renal disease | 5 (6.8%) | 3 (3.6%) | |
| Others/unknown | 5 (6.8%) | 6 (7.2%) | |
|
| |||
| Diabetes Mellitus | 9 (12.2%) | 14 (16.9%) | 0.510 |
| Hypertension | 52 (70.3%) | 66 (79.5%) | 0.234 |
| Heart disease | 31 (41.9%) | 33 (39.8%) | 0.792 |
| Previous abdominal operation | 18 (24.3%) | 24 (28.9%) | 0.526 |
| Previous KTx | 7 (9.5%) | 12 (14.5%) | 0.388 |
| Previous abdominal operation | 17 (23.0%) | 24 (28.9%) | 0.490 |
| Previous nephrectomy | 10 (13.5%) | 20 (24.1%) | 0.154 |
| Dialysis | 70 (94.6%) | 76 (91.6%) | 0.442 |
| Haemodialysis | 59 (79.7%) | 70 (84.3%) | 0.471 |
| Peritoneal dialysis | 17 (22.9%) | 9 (10.8%) |
|
| Preoperative dialysis (months) | 57.1 ± 39.0 (1–140) | 68 ± 49.8 (1–274) | 0.163 |
| Side of KTx (Left/Right) | 39 (52.7%)/35 (47.3%) | 40 (48.2%)/43 (51.8%) | 0.549 |
| Duration of operation (minutes) | 195.3 ± 61.0 | 206.1 ± 56.0 | 0.304 |
| Main immunosuppression | 0.072 | ||
| Ciclosporin/Tacrolimus | 12 (16.2%)/62 (83.8%) | 24 (28.9%)/59 (71.1%) | |
|
| |||
| Symptomatic | 57 (77.0%) | 63 (75.9%) | 0.831 |
| Recurrence | 36 (48.6%) | 37 (44.6%) | 0.649 |
| Graft rejection | 1 (1.4%) | 3 (3.6%) | 0.457 |
|
|
| ||
| Grade A | 21 (28.2%) | 24 (28.9%) | 0.987 |
| Grade B | 22 (29.7%) | 8 (9.6%) |
|
| Grade C | 31 (42.1%) | 51 (61.4%) |
|
| Duration of hospital stay | 22.8 ± 15.3 (9–95) | 27.6 ± 20.1 (6–165) | 0.115 |
Abbreviations: BMI, body mass index; KTx, kidney transplantation.
Univariate and multivariate logistic regression of predictive factors for grade C of lymphoceles after KTx.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Donor age (≥60 y/o) | 0.845 | 0.213–3.353 | 0.556 | |||
| Donor gender | 1.434 | 0.666–3.087 | 0.233 | |||
| Donor BMI (≥30 kg/m2) | 1.179 | 0.540–2.578 | 0.413 | |||
| Brain dead/ Living donor | 0.397 | 0.164–0.963 | 0.041 | 0.590 | 0.222–1569 | 0.290 |
| Reciepient age (≥60 y/o) | 1.079 | 0.496–2.350 | 0.500 | |||
| Reciepient gender (male vs. female) | 0.823 | 0.373–1.819 | 0.387 | |||
| Reciepient BMI (≥30 kg/m2) | 0.903 | 0.273–2.981 | 0.566 | |||
| Cardiovascular diseases | 0.699 | 0.316–1.547 | 0.247 | |||
| Hypertension | 1.366 | 0.537–3.471 | 0.340 | |||
| Diabetes mellitus | 0.659 | 0.207–2.098 | 0.341 | |||
| Hepatic diseases | 1.774 | 0.775–4.061 | 0.127 | 1.145 | 0.439–2.985 | 0.782 |
| Previous abdominal operation | 2.156 | 1.002–4.645 | 0.050 | 1.824 | 0.794–4.189 | 0.156 |
| Previous KTx | 0.885 | 0.271–2.887 | 0.552 | |||
| Hemodialysis | 0.716 | 0.175–2.937 | 0.444 | |||
| Peritoneal dialysis | 1.003 | 0.995–1.010 | 0.084 | 3.614 | 1.215–10.747 |
|
| Nephrectomy | 1.000 | 0.386–2.588 | 0.605 | |||
| Side of KTx (Left/ Right) | 2.531 | 1.295–4.946 | 0.007 | 2.842 | 1.354–5.967 |
|
| Preventive fenestration | 0.453 | 0.232–0.886 | 0.021 | 0.334 | 0.153–0.730 |
|
| Immunosuppression (Ciclosporin vs. Tacrolimus) | 0.577 | 0.247–1.348 | 0.147 | 0.606 | 0.232–1.586 | 0.308 |
Abbreviations: OR, odds ratio; CI, confidence interval; KTx, kidney transplantation.